471 related articles for article (PubMed ID: 28481005)
1. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells.
Milosavljevic N; Gazdic M; Simovic Markovic B; Arsenijevic A; Nurkovic J; Dolicanin Z; Djonov V; Lukic ML; Volarevic V
Liver Transpl; 2017 Aug; 23(8):1040-1050. PubMed ID: 28481005
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury.
Gazdic M; Markovic BS; Arsenijevic A; Jovicic N; Acovic A; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML; Volarevic V
Liver Transpl; 2018 May; 24(5):687-702. PubMed ID: 29500914
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.
Gazdic M; Simovic Markovic B; Vucicevic L; Nikolic T; Djonov V; Arsenijevic N; Trajkovic V; Lukic ML; Volarevic V
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1173-e1185. PubMed ID: 28488390
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells attenuate liver fibrosis by suppressing Th17 cells - an experimental study.
Milosavljevic N; Gazdic M; Simovic Markovic B; Arsenijevic A; Nurkovic J; Dolicanin Z; Jovicic N; Jeftic I; Djonov V; Arsenijevic N; Lukic ML; Volarevic V
Transpl Int; 2018 Jan; 31(1):102-115. PubMed ID: 28805262
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoke attenuates mesenchymal stem cell-based suppression of immune cell-driven acute liver failure.
Pavlovic D; Miloradovic D; Stojanovic MD; Harrell CR; Polosa R; Rust S; Volti GL; Caruso M; Jakovljevic V; Djonov V; Volarevic V
Toxicol Lett; 2023 Aug; 385():12-20. PubMed ID: 37572970
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8(+) T cell proliferation by human mesenchymal stromal cells.
Hong J; Hueckelhoven A; Wang L; Schmitt A; Wuchter P; Tabarkiewicz J; Kleist C; Bieback K; Ho AD; Schmitt M
Cytotherapy; 2016 May; 18(5):621-9. PubMed ID: 27008974
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
[TBL] [Abstract][Full Text] [Related]
8. The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets.
Özdemir AT; Özgül Özdemir RB; Kırmaz C; Sarıboyacı AE; Ünal Halbutoğlları ZS; Özel C; Karaöz E
Cell Immunol; 2016 Dec; 310():108-115. PubMed ID: 27576175
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation.
Tatara R; Ozaki K; Kikuchi Y; Hatanaka K; Oh I; Meguro A; Matsu H; Sato K; Ozawa K
Cytotherapy; 2011 Jul; 13(6):686-94. PubMed ID: 21171824
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment.
François S; Usunier B; Forgue-Lafitte ME; L'Homme B; Benderitter M; Douay L; Gorin NC; Larsen AK; Chapel A
Stem Cells Transl Med; 2019 Mar; 8(3):285-300. PubMed ID: 30451398
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.
Huang B; Cheng X; Wang H; Huang W; la Ga Hu Z; Wang D; Zhang K; Zhang H; Xue Z; Da Y; Zhang N; Hu Y; Yao Z; Qiao L; Gao F; Zhang R
J Transl Med; 2016 Feb; 14():45. PubMed ID: 26861623
[TBL] [Abstract][Full Text] [Related]
12. Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells.
Goubier A; Vocanson M; Macari C; Poyet G; Herbelin A; Nicolas JF; Dubois B; Kaiserlian D
J Invest Dermatol; 2013 Apr; 133(4):980-7. PubMed ID: 23190881
[TBL] [Abstract][Full Text] [Related]
13. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.
Ling W; Zhang J; Yuan Z; Ren G; Zhang L; Chen X; Rabson AB; Roberts AI; Wang Y; Shi Y
Cancer Res; 2014 Mar; 74(5):1576-87. PubMed ID: 24452999
[TBL] [Abstract][Full Text] [Related]
15. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure.
Harrell CR; Pavlovic D; Djonov V; Volarevic V
World J Gastroenterol; 2022 Jul; 28(28):3627-3636. PubMed ID: 36161038
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells and a vitamin D receptor agonist additively suppress T helper 17 cells and the related inflammatory response in the kidney.
Duffy MM; McNicholas BA; Monaghan DA; Hanley SA; McMahon JM; Pindjakova J; Alagesan S; Fearnhead HO; Griffin MD
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1412-26. PubMed ID: 25339699
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway.
Lathrop MJ; Brooks EM; Bonenfant NR; Sokocevic D; Borg ZD; Goodwin M; Loi R; Cruz F; Dunaway CW; Steele C; Weiss DJ
Stem Cells Transl Med; 2014 Feb; 3(2):194-205. PubMed ID: 24436442
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cardiac allograft rejection in mice using interleukin-35-modified mesenchymal stem cells.
Wang W; Zhao N; Li B; Gao H; Yan Y; Guo H
Scand J Immunol; 2019 Apr; 89(4):e12750. PubMed ID: 30664805
[TBL] [Abstract][Full Text] [Related]
20. NK1.1
An JN; Ryu S; Kim YC; Yoo KD; Lee J; Kim HY; Lee H; Lee JP; Lee JW; Jeon US; Kim DK; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2021 May; 320(5):F772-F788. PubMed ID: 33719574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
